Cipla Announces Leadership Changes Following Board Meeting
Mumbai – Cipla Limited announced several leadership changes following a board meeting held on March 30, 2026. The changes are effective April 1, 2026.Upon Achin Gupta assuming the role of Managing Director and Global Chief Executive Officer, Saurabh Gambhir has been categorized as Senior Management Personnel (SMP), Head - Strategy and M&A (Global). Similarly, Satyavan Manikani has also been designated as SMP, serving as Chief Portfolio Head Global.
Umang Vohra, who completed his term as Managing Director and Global Chief Executive Officer on March 31, 2026, has resigned from his position as a Director of the Company.
Leadership Profiles
Saurabh Gambhir, Head - Strategy and Mergers & Acquisitions (Global), plays a key role in shaping Cipla's long-term strategic direction and driving transformation initiatives. Previously, he held senior roles at Emcure Pharmaceuticals and Intas Pharmaceuticals. He holds an MBA from the Indian Institute of Management, Ahmedabad.
Satyavan Manikani, Chief Portfolio Head Global, leads Cipla’s portfolio initiatives globally. Prior to joining Cipla in February 2022, he held leadership positions at USV Limited, Gufic Biosciences Ltd, Alkem Labs, and Ranbaxy Labs. Manikani holds a pharmacy degree and an MBA in Marketing.
Resignation of Umang Vohra
In a letter to the Board of Directors, Umang Vohra expressed gratitude for his ten years at Cipla and wished the company continued success.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.